Socioeconomic cost of AML in Sweden—A population‐based study using multiple nation‐wide registers

Acute myeloid leukemia (AML) is associated with a high economic and clinical burden. Recently novel therapies have been added to standard treatment regimens. Here, we evaluated the economic impact of AML up until the introduction of these novel therapies. Individual data on 2954 adult patients diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernlund, Emma, Redig, Josefine, Paulsson, Björn, Rangert Derolf, Åsa, Höglund, Martin, Vertuani, Simona, Juliusson, Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Haematologic Malignancy ‐ Myeloid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176098/
https://www.ncbi.nlm.nih.gov/pubmed/35844713
http://dx.doi.org/10.1002/jha2.208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176098/
https://www.ncbi.nlm.nih.gov/pubmed/35844713
http://dx.doi.org/10.1002/jha2.208

Ejemplares similares